68 related articles for article (PubMed ID: 12839846)
1. Prediction of the axillary lymph-node metastatic burden of breast cancer by
Li Y; Han D; Shen C
BMC Cancer; 2024 Jun; 24(1):704. PubMed ID: 38849770
[TBL] [Abstract][Full Text] [Related]
2. (18)F-FDG PET/CT with Contrast Enhancement for Evaluation of Axillary Lymph Node Involvement in T1 Breast Cancer.
Kong EJ; Chun KA; Cho IH; Lee SJ
Nucl Med Mol Imaging; 2010 Sep; 44(3):170-6. PubMed ID: 24899946
[TBL] [Abstract][Full Text] [Related]
3. Mapping of PET/CT-based regional nodes distribution of recurrent/advanced breast cancer and comparison with current delineation atlas.
Zhang M; Cao L; Chen J; Li B; Huang X; Cai G; Xu C
Br J Radiol; 2022 Sep; 95(1137):20220382. PubMed ID: 35731844
[TBL] [Abstract][Full Text] [Related]
4. An evaluation of molecular markers for improved detection of breast cancer metastases in sentinel nodes.
Abdul-Rasool S; Kidson SH; Panieri E; Dent D; Pillay K; Hanekom GS
J Clin Pathol; 2006 Mar; 59(3):289-97. PubMed ID: 16505281
[TBL] [Abstract][Full Text] [Related]
5. Detection of internal mammary chain infiltration in breast cancer patients by [
Garcia JR; Kauak M; Compte A; Bassa P; Llinares E; Valls E; Riera E
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2024; 43(2):73-78. PubMed ID: 37865228
[TBL] [Abstract][Full Text] [Related]
6. More than meets the eye: 2-[
Huang W; Son MH; Ha LN; Kang L; Cai W
Eur J Nucl Med Mol Imaging; 2024 May; 51(6):1725-1728. PubMed ID: 38424238
[No Abstract] [Full Text] [Related]
7. Diagnostic Performance of FDG-PET/CT Scan as Compared to US-Guided FNA in Prediction of Axillary Lymph Node Involvement in Breast Cancer Patients.
Assi HI; Alameh IA; Khoury J; Bou Zerdan M; Akiki V; Charafeddine M; El Saheb GI; Sukhon F; Sbaity E; Baydoun S; Shabb N; Berjawi G; Haidar MB
Front Oncol; 2021; 11():740336. PubMed ID: 34660301
[TBL] [Abstract][Full Text] [Related]
8. A Prospective Study Comparing the Role of 18 FDG PET-CT with Contrast-Enhanced Computed Tomography and Tc99m Bone Scan for Staging Locally Advanced Breast Cancer.
Bhoriwal S; Deo SVS; Kumar R; Thulkar S; Gogia A; Sharma DN; Mathur S
Indian J Surg Oncol; 2021 Jun; 12(2):266-271. PubMed ID: 34295069
[TBL] [Abstract][Full Text] [Related]
9. Pretherapeutic Imaging for Axillary Staging in Breast Cancer: A Systematic Review and Meta-Analysis of Ultrasound, MRI and FDG PET.
Le Boulc'h M; Gilhodes J; Steinmeyer Z; Molière S; Mathelin C
J Clin Med; 2021 Apr; 10(7):. PubMed ID: 33917590
[TBL] [Abstract][Full Text] [Related]
10. Imaging the lymphatic system.
Munn LL; Padera TP
Microvasc Res; 2014 Nov; 96():55-63. PubMed ID: 24956510
[TBL] [Abstract][Full Text] [Related]
11. A systematic review of FDG-PET in breast cancer.
Escalona S; Blasco JA; Reza MM; Andradas E; Gómez N
Med Oncol; 2010 Mar; 27(1):114-29. PubMed ID: 19277913
[TBL] [Abstract][Full Text] [Related]
12. Selective Sentinel Node Plus Additional Non-Sentinel Node Biopsy Based on an FDG-PET/CT Scan in Early Breast Cancer Patients: Single Institutional Experience.
Kim J; Lee J; Chang E; Kim S; Suh K; Sul J; Song I; Kim Y; Lee C
World J Surg; 2009 May; 33(5):943-9. PubMed ID: 19259728
[TBL] [Abstract][Full Text] [Related]
13. Non-sentinel lymph node metastases associated with isolated breast cancer cells in the sentinel node.
van Deurzen CH; de Boer M; Monninkhof EM; Bult P; van der Wall E; Tjan-Heijnen VC; van Diest PJ
J Natl Cancer Inst; 2008 Nov; 100(22):1574-80. PubMed ID: 19001602
[TBL] [Abstract][Full Text] [Related]
14. Utility of 18F-fluoro-deoxyglucose emission tomography/computed tomography fusion imaging (18F-FDG PET/CT) in combination with ultrasonography for axillary staging in primary breast cancer.
Ueda S; Tsuda H; Asakawa H; Omata J; Fukatsu K; Kondo N; Kondo T; Hama Y; Tamura K; Ishida J; Abe Y; Mochizuki H
BMC Cancer; 2008 Jun; 8():165. PubMed ID: 18541009
[TBL] [Abstract][Full Text] [Related]
15. Early breast cancer.
Suzuki T; Toi M; Saji S; Horiguchi K; Aruga T; Suzuki E; Horiguchi S; Funata N; Karasawa K; Kamata N
Int J Clin Oncol; 2006 Apr; 11(2):108-19. PubMed ID: 16622745
[TBL] [Abstract][Full Text] [Related]
16. Imaging in breast cancer: Single-photon computed tomography and positron-emission tomography.
Bénard F; Turcotte E
Breast Cancer Res; 2005; 7(4):153-62. PubMed ID: 15987467
[TBL] [Abstract][Full Text] [Related]
17. Use of tomographic nuclear medicine procedures, SPECT and pinhole SPECT, with cationic lipophilic radiotracers for the evaluation of axillary lymph node status in breast cancer patients.
Madeddu G; Spanu A
Eur J Nucl Med Mol Imaging; 2004 Jun; 31 Suppl 1():S23-34. PubMed ID: 15085293
[TBL] [Abstract][Full Text] [Related]
18. Imaging the lymphatic system: possibilities and clinical applications.
Clément O; Luciani A
Eur Radiol; 2004 Aug; 14(8):1498-507. PubMed ID: 15007613
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of fluorodeoxyglucose positron emission tomography in the detection of axillary lymph node metastases in patients with early-stage breast cancer.
Barranger E; Grahek D; Antoine M; Montravers F; Talbot JN; Uzan S
Ann Surg Oncol; 2003 Jul; 10(6):622-7. PubMed ID: 12839846
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
